| A review on anticancer potential of bioactive heterocycle quinoline O Afzal, S Kumar, MR Haider, MR Ali, R Kumar, M Jaggi, S Bawa European Journal of Medicinal Chemistry 97, 871-910, 2015 | 795 | 2015 |
| Medicinal prospects of antioxidants: A review K Neha, MR Haider, A Pathak, MS Yar European journal of medicinal chemistry 178, 687-704, 2019 | 683 | 2019 |
| Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities J Akhtar, AA Khan, Z Ali, R Haider, MS Yar European journal of medicinal chemistry 125, 143-189, 2017 | 462 | 2017 |
| Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains F Naaz, MR Haider, S Shafi, MS Yar European journal of medicinal chemistry 171, 310-331, 2019 | 171 | 2019 |
| Free radical scavengers: An overview on heterocyclic advances and medicinal prospects K Haider, MR Haider, K Neha, MS Yar European Journal of Medicinal Chemistry 204, 112607, 2020 | 87 | 2020 |
| "Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. MSA Akhtar, Md Jawaid, Ahsan Ahmed Khan, Zulphikar Ali, Rikeshwer Prasad ... Bioorganic Chemistry 78, 2018 | 85 | 2018 |
| Current perspectives on quinazolines with potent biological activities: A review T Gupta, A Rohilla, A Pathak, MJ Akhtar, MR Haider, MS Yar Synthetic Communications 48 (10), 1099-1127, 2018 | 84 | 2018 |
| Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder NK Bari, M Fazil, MQ Hassan, MR Haider, B Gaba, JK Narang, S Baboota, ... International journal of biological macromolecules 81, 49-59, 2015 | 83 | 2015 |
| Recent progress of benzimidazole hybrids for anticancer potential MJ Akhtar, MS Yar, VK Sharma, AA Khan, Z Ali, MD Haider, A Pathak Current Medicinal Chemistry 27 (35), 5970-6014, 2020 | 56 | 2020 |
| DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective A Pathak, A Rohilla, T Gupta, MJ Akhtar, MR Haider, K Sharma, K Haider, ... European Journal of Medicinal Chemistry 158, 559-592, 2018 | 47 | 2018 |
| Novel 9-(2-(1-arylethylidene) hydrazinyl) acridine derivatives: Target Topoisomerase 1 and growth inhibition of HeLa cancer cells MR Haider, K Ahmad, N Siddiqui, Z Ali, MJ Akhtar, N Fuloria, S Fuloria, ... Bioorganic chemistry 88, 102962, 2019 | 39 | 2019 |
| Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review K Haider, A Pathak, A Rohilla, MR Haider, K Ahmad, MS Yar European journal of medicinal chemistry 184, 111773, 2019 | 37 | 2019 |
| Design and synthesis of quinazoline-3, 4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor Z Ali, MJ Akhtar, MR Haider, AA Khan, AA Siddiqui, MS Yar Bioorganic chemistry 71, 181-191, 2017 | 32 | 2017 |
| Design, synthesis, and biological evaluation of imidazopyridine‐linked thiazolidinone as potential anticancer agents MA Iqbal, A Husain, O Alam, SA Khan, A Ahmad, MR Haider, MA Alam Archiv der Pharmazie 353 (10), 2000071, 2020 | 26 | 2020 |
| Design, synthesis, and biological evaluation of novel quinazoline clubbed thiazoline derivatives Z Ali, MJ Akhtar, AA Siddiqui, AA Khan, MR Haider, MS Yar Archiv der Pharmazie 350 (2), 1600298, 2017 | 22 | 2017 |
| Recent advances in the synthesis and anticancer activity of some molecules other than nitrogen containing heterocyclic moeities MJ Akhtar, MS Yar, AA Khan, Z Ali, MR Haider Mini Reviews in Medicinal Chemistry 17 (17), 1602-1632, 2017 | 21 | 2017 |
| Indole derivatives (2010–2020) as versatile tubulin inhibitors: Synthesis and structure–activity relationships F Naaz, K Neha, MR Haider, S Shafi Future Medicinal Chemistry 13 (20), 1795-1828, 2021 | 20 | 2021 |
| current quest in natural bioactive compounds for Alzheimer’s disease: Multi-targeted-designed-ligand based approach with preclinical and clinical based evidence A Iqubal, SO Rahman, M Ahmed, P Bansal, MR Haider, MK Iqubal, ... Current Drug Targets 22 (6), 685-720, 2021 | 20 | 2021 |
| Design, in-silico study and biological evaluation of newly synthesized 3-chlorobenzofuran congeners as antitubercular agents MM Abdullah, NA Siddiqui, RA Mothana, FA Nasr, AJ Al-Rehaily, ... Arabian Journal of Chemistry 14 (4), 103034, 2021 | 4 | 2021 |
| Molecular interactions of vinclozolin metabolites with human estrogen receptors 1GWR-α and 1QKM and androgen receptor 2AM9-β: Implication for endocrine disruption H Habib, MR Haider, S Sharma, MMA Beg, S Ahmad, S Dabeer, MS Yar, ... Toxicology Mechanisms and Methods 30 (5), 370-377, 2020 | 4 | 2020 |
Mohammad Shahar Yar, ProfessorJamia Hamdard在 jamiahamdard.ac.in 的电子邮件经过验证
